1,25(OH)2D3 suppresses expression and secretion of atrial natriuretic peptide from cardiac myocytes

J. Wu, M. Garami, L. Cao, Q. Li, D. G. Gardner

Research output: Contribution to journalArticle

59 Citations (Scopus)


We have examined the effects of 1,25-dihydroxyvitamin D3 [1,25(OH)2 D3] on the expression of the rat atrial natriuretic peptide (ANP) gene and the secretion of the encoded protein product in neonatal rat cardiac myocyte cultures. 1,25(OH)2D3 effected a dose- and time-dependent inhibition of agonist-stimulated ANP secretion, which was accompanied by a reduction in the levels of the ANP mRNA transcript. The latter effect appeared to derive, at least in part, from suppression of ANP gene transcription. Of interest, both the reduction in mRNA levels and the inhibition of transcriptional activity were amplified by simultaneous treatment with retinoic acid, suggesting that heterodimerization of liganded 1,25(OH)2D3 receptor and retinoic acid receptor (likely retinoid X receptor) may underlie the inhibitory mechanism in the cardiac myocyte. Neither the secretory effect nor the effect on transcription proved to be calcium dependent. 22-Oxacalcitriol, a nonhypercalcemic analogue of 1,25(OH)2D3, was equally effective in suppressing ANP mRNA levels and transcription of the gene. These findings add to a growing body of data that imply an important role for 1,25(OH)2D3 in the regulation of cardiovascular function.

Original languageEnglish
Pages (from-to)E1108-E1113
JournalAmerican Journal of Physiology - Endocrinology and Metabolism
Issue number6 31-6
Publication statusPublished - 1995


  • 22-oxacalcitriol
  • cardiac hypertrophy
  • gene expression
  • vitamin D

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Physiology
  • Physiology (medical)

Fingerprint Dive into the research topics of '1,25(OH)<sub>2</sub>D<sub>3</sub> suppresses expression and secretion of atrial natriuretic peptide from cardiac myocytes'. Together they form a unique fingerprint.

  • Cite this